BioMarin Pharmaceutical Inc. (OQ:BMRN)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BMRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 13th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 30/20 Jun 29/20 Mueller Brian Direct Ownership Stock Option (Right to buy Common Stock) A - Grant, award or other under Rule 16b-3(d) 13,230  
Jun 30/20 Jun 29/20 Mueller Brian Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,640  
Jun 30/20 Jun 26/20 Dere Willard H Direct Ownership Common Stock S - Open market or private sale -4,430 $123.61
Jun 23/20 Jun 19/20 Ajer Jeffrey Robert Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Jun 23/20 Jun 19/20 Ajer Jeffrey Robert Direct Ownership Common Stock S - Open market or private sale -15,000 $124.00
Jun 23/20 Jun 19/20 Ajer Jeffrey Robert Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,000 $63.10
Jun 9/20 Jun 5/20 Lawlis V Bryan Direct Ownership Common Stock S - Open market or private sale -4,430 $107.46
May 29/20 May 27/20 Slamon Dennis Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,300  
May 29/20 May 27/20 Pyott David E I Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,300  
May 29/20 May 27/20 Meier Richard A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,300  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BMRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 13th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 30/20 Jun 29/20 Mueller Brian Direct Ownership Stock Option (Right to buy Common Stock) A - Grant, award or other under Rule 16b-3(d) 13,230  
Jun 30/20 Jun 29/20 Mueller Brian Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,640  
Jun 30/20 Apr 30/20 Mueller Brian Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 323 $62.59
Jun 30/20 Jun 26/20 Dere Willard H Direct Ownership Common Stock S - Open market or private sale -4,430 $123.61
Jun 23/20 Jun 19/20 Ajer Jeffrey Robert Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Jun 23/20 Jun 19/20 Ajer Jeffrey Robert Direct Ownership Common Stock S - Open market or private sale -15,000 $124.00
Jun 23/20 Jun 19/20 Ajer Jeffrey Robert Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,000 $63.10
Jun 23/20 Apr 30/20 Ajer Jeffrey Robert Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 338 $62.59
Jun 9/20 Jun 5/20 Lawlis V Bryan Direct Ownership Common Stock S - Open market or private sale -4,430 $107.46
May 29/20 May 27/20 Slamon Dennis Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,300  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BMRN

Competitors

Competitors with Recent Insider Filings
Allakos (OQ:ALLK)
ChemoCentryx (OQ:CCXI)
Twist Bioscience (OQ:TWST)